(“NetScientific” or the “Company”)
Notice of AGM
London, UK – 1 June 2020 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, announces that in accordance with AIM Rules 20 and 26 the Company’s Notice of Annual General Meeting has been sent to Shareholders today and is available on the Company’s website in the Investor Relations section at http://www.netscientific.net/investors.
The Annual General Meeting will be held on Wednesday, 24 June 2020 at 11.00 a.m. at Level 39, One Canada Square, London E14 5AB, United Kingdom.
The Board of Directors of the Company (the “Board”) believe that all the proposed resolutions set out in the Notice are in the best interests of the Company and its Shareholders as a whole. The Board recommends that you vote in favour of the proposed resolutions, as they intend to do in respect of their own beneficial shareholdings.
As Shareholders will be aware, the UK Government’s announcement on 23 March 2020 of new restrictive measures in connection with COVID-19 and, in particular, the restrictions on non-essential travel and on gatherings exceeding two persons will restrict the ability of Shareholders to attend the Meeting in person. Although the situation is fast changing and constantly evolving, it appears that the measures in force as of 23 March 2020 will continue beyond the date of the Meeting and as such the Board strongly advises and recommends that all Shareholders refrain from attending the Meeting in person and, instead, submit a Form of Proxy before the deadline of 11:00 a.m. on Monday 22 June 2020. Please read the Notice for further details on submitting a proxy.
# # #
For more information, please contact:
Ilian Iliev, CEO
|Tel: +44 (0)20 3514 1800|
|WHIreland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Darshan Patel
|Tel: +44 (0)20 7220 1666|
|MO PR ADVISORY (Press Contact)
|Tel: +44 (0)78 7644 4977|
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
For more information, please visit the website at www.NetScientific.net